Union Korea Pharm Revises Kosdaq Trading Suspension Period for Investor Protection
Bitget2026/11/02 07:27- Union Korea Pharm’s KOSDAQ-listed common shares face a revised trading suspension from April 7, 2026, under KOSDAQ market rules for investor protection.
- The suspension remains pending confirmation of a court ruling on an injunction seeking to suspend the delisting decision.
- Capital-reduction provisions also keep trading suspended until replacement shares are listed if a listing application is completed within one month of the trigger.
- Otherwise, the suspension continues through the day before delisting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound hits session highs at 1.3420 amid broadbased US Dollar weakness
Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.
Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.
Crypto prices
More
